NGM
NGM Biopharmaceuticals, Inc. Common Stock
NGM
NGM
Delisted
NGM was delisted on the 4th of April, 2024.
94 hedge funds and large institutions have $50.6M invested in NGM Biopharmaceuticals, Inc. Common Stock in 2023 Q3 according to their latest regulatory filings, with 12 funds opening new positions, 30 increasing their positions, 35 reducing their positions, and 24 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less first-time investments, than exits
New positions opened: | Existing positions closed:
59% less capital invested
Capital invested by funds: $124M → $50.6M (-$73.8M)
Holders
94
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$928K | |
| 2 | +$294K | |
| 3 | +$289K | |
| 4 |
EC
Euclidean Capital
New York
|
+$263K |
| 5 |
Squarepoint
New York
|
+$149K |
Top Sellers
| 1 | -$849K | |
| 2 | -$601K | |
| 3 | -$450K | |
| 4 |
Connor, Clark & Lunn Investment Management (CC&L)
Vancouver,
British Columbia, Canada
|
-$315K |
| 5 |
HF
HRT Financial
New York
|
-$265K |